Biochemical markers predictive for bone marrow involvement in systemic mastocytosis

17Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Systemic mastocytosis is characterized by bone marrow involvement, which requires a bone marrow biopsy for diagnostic work-up. We questioned whether bone marrow involvement could be predicted using biochemical markers. We selected patients with various symptoms suggestive of indolent systemic mastocytosis, of whom 63 ultimately had bone marrow involvement. Patients suspected of aggressive mastocytosis, or mastocytosis associated with other hematologic diseases were excluded. Evaluation of 115 patients and 15 patient controls demonstrated a test accuracy for serum tryptase, urinary N- methylhistamine and N - methylimidazole acetic acid of 96%, 88% and 95% respectively. These markers provide an excellent pre-test probability of indolent systemic mastocytosis. ©2008 Ferrata Storti Foundation.

Cite

CITATION STYLE

APA

Donker, M. L., Van Doormaal, J. J., Van Doormaal, F. F., Kluin, P. M., Van Der Veer, E., De Monchy, J. G. R., … Kluin-Nelemans, H. C. (2008). Biochemical markers predictive for bone marrow involvement in systemic mastocytosis. Haematologica, 93(1), 120–123. https://doi.org/10.3324/haematol.11558

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free